Sagimet Biosciences Inc. - Seri

Historical 13F Holders

Symbol
SGMT
CUSIP
786700104
All holders as of
Q2 2026
Type
Equity
Class
COM SER A
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 786700104 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G 7.8% 7/30/2026
Event 6/30/2026
Commodore Capital LP 13G
7.6% 10/7/2026
Event 9/30/2026
Balyasny Asset Management L.P. 13G
5.9% 8/14/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (6)
AP11 Ltd 13G/A
4.9% 6/24/2025
Event 6/24/2025
Woodline Partners LP 13G/A 4.8% 11/14/2025
Event 9/30/2025
Blue Owl Capital Holdings LP 13G/A 4.3% 2/14/2025
Event 12/31/2024
KPCB Pandemic & Bio Defense Fund LLC 13G/A
0% 12/18/2025
Event 12/18/2025
New Enterprise Associates 13, L.P. 13G/A
0% 5/13/2025
Event 3/31/2025
Point72 Asset Management, L.P. 13G/A
0% 8/14/2025
Event 6/30/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 520 $5.14 k
2026 Q2 129 51.0 M $395 M
2026 Q1 93 13.4 M $69.8 M
2025 Q4 93 14.4 M $85.2 M
2025 Q3 79 12.6 M $86.7 M
2025 Q2 76 11.8 M $90.1 M
2025 Q1 77 13.8 M $44.9 M
2024 Q4 72 17.5 M $78.8 M
2024 Q3 70 19.7 M $54.6 M
2024 Q2 88 21.3 M $72.9 M
2024 Q1 85 23.9 M $130 M
2023 Q4 54 14.5 M $76.2 M
2023 Q3 50 15.6 M $130 M